Ibandronate: pharmacology and preclinical studies.
Over the past three decades, changes to the chemical structures of the bisphosphonates have resulted in progressive improvements in their antiresorptive potencies. Ibandronate is a potent, nitrogen-containing bisphosphonate that possesses a tertiary nitrogen group on its R2 side chain and a hydroxyl...
Main Author: | Russell, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.
by: Bauss, F, et al.
Published: (2004) -
Intermittent intravenous ibandronate therapy for osteoporosis
by: L I Alekseeva, et al.
Published: (2008-09-01) -
VIBE: Evaluation of Ibandronate Efficacy - Original Investigation
by: J-Y Reginster, et al.
Published: (2008-12-01) -
VIBE: Evaluation of Ibandronate Efficacy - Original Investigation
by: J-Y Reginster, et al.
Published: (2008-12-01) -
Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
by: Mabilleau, G, et al.
Published: (2011)